
The transaction will consummate only after a nod from the Competition Commission (CCI), they said. Pai currently holds a 51% in MHE, followed by 20% by PE fund TPG Group, 18% by Temasek, 10% by National Investment & Infrastructure Fund (NIIF) and 1% by employees.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aJXbAFd
via
IFTTT
0 comments:
Post a Comment